Somanetics Corp. (SMTS) Posts Q2 EPS of $0.12, In-Line with Views
Somanetics Corp. (Nasdaq: SMTS) reports Q2 EPS of $0.12, versus the analyst estimate of $0.12. Revenue for the quarter was $13.9 million, which compares to the estimate of $13.77 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Rue21, Inc. (RUE) Tops Q1 EPS by 3c; Boosts FY12 EPS Outlook; Approves $50M Buyback
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
